Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature

M Piroozkhah, A Aghajani, P Jalali… - Frontiers in …, 2023 - frontiersin.org
Introduction Colorectal cancer (CRC) is a devastating disease that affects millions of people
worldwide. Recent research has highlighted the crucial role of the guanylate cyclase-C (GC …

Receptor guanylyl cyclase C and cyclic GMP in health and disease: perspectives and therapeutic opportunities

H Prasad, JKK Mathew… - Frontiers in Endocrinology, 2022 - frontiersin.org
Receptor Guanylyl Cyclase C (GC-C) was initially characterized as an important regulator of
intestinal fluid and ion homeostasis. Recent findings demonstrate that GC-C is also causally …

Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C

V Mishra, A Bose, S Kiran, S Banerjee… - Journal of Experimental …, 2021 - rupress.org
Activating mutations in receptor guanylyl cyclase C (GC-C), the target of gastrointestinal
peptide hormones guanylin and uroguanylin, and bacterial heat-stable enterotoxins cause …

The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer's Disease Reveals New Insights for AD Study

LJ Rochín-Hernández, MA Jiménez-Acosta… - International Journal of …, 2023 - mdpi.com
Alzheimer's disease (AD), the most common neurodegenerative disease and the first cause
of dementia worldwide, has no effective treatment, and its pathological mechanisms are not …

Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics

KN Pandey - Frontiers in Molecular Neuroscience, 2023 - frontiersin.org
The natriuretic peptides (NPs) hormone family, which consists mainly of atrial, brain, and C-
type NPs (ANP, BNP, and CNP), play diverse roles in mammalian species, ranging from …

Research progress of antibody–drug conjugate therapy for advanced gastric cancer

N Wang, Q Mei, Z Wang, L Zhao, D Zhang… - Frontiers in …, 2022 - frontiersin.org
Gastric cancer is an intractable malignant tumor that has the fifth highest morbidity and the
third highest mortality in the world. Even though various treatment options did much to …

[HTML][HTML] Impaired intestinal sodium transport in inflammatory bowel disease: from the passenger to the driver's seat

H Prasad, SS Visweswariah - Cellular and molecular gastroenterology and …, 2021 - Elsevier
While impaired intestinal sodium transport has been described for decades as a ubiquitous
feature of inflammatory bowel disease (IBD), whether and how it plays a pivotal role in the …

The evolutionary divergence of receptor guanylyl cyclase C has implications for preclinical models for receptor-directed therapeutics

V Mishra, K Sharma, A Bose, P Maisonneuve… - Journal of Biological …, 2024 - ASBMB
Mutations in receptor guanylyl cyclase C (GC-C) cause severe gastrointestinal disease,
including meconium ileus, early onset acute diarrhea, and pediatric inflammatory bowel …

Novel GUCY2C variant causing familial diarrhea in a Mennonite kindred and a potential therapeutic approach

RM Wolfe, AW Mohsen… - American Journal of …, 2021 - Wiley Online Library
Abstract Guanylate cyclase 2C (GC‐C), encoded by the GUCY2C gene, is implicated in
hereditary early onset chronic diarrhea. Several families with chronic diarrhea symptoms …

The pseudokinase domain in receptor guanylyl cyclases

A Bose, SS Visweswariah - Methods in enzymology, 2022 - Elsevier
Cyclic GMP is produced by enzymes called guanylyl cyclases, of which the membrane-
associated forms contain an intracellular pseudokinase domain that allosterically regulates …